United States Antimony (UAMY) Cash & Equivalents (2010 - 2026)

United States Antimony has reported Cash & Equivalents for 15 years, with the latest figure at $30.5 million in Q4 2025.

• Quarterly Cash & Equivalents rose 67.81% year-over-year to $30.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $30.5 million (up 67.81% YoY) and the FY2025 annual result came in at $30.5 million, up 67.81% from the prior year.
• Cash & Equivalents advanced to $30.5 million in Q4 2025 per UAMY's latest filing, from $18.5 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $30.5 million in Q4 2025 and troughed at $5.8 million in Q2 2025.
• A 5-year average of $16.4 million and a median of $16.8 million in 2023 frame the typical range for Cash & Equivalents.
• The sharpest annual moves came in 2021 and 2022: Cash & Equivalents jumped 100037.01% in 2021, then plunged 64.31% in 2022.
• Over 5 years, Cash & Equivalents stood at $21.4 million in 2021, then fell by 10.75% to $19.1 million in 2022, then tumbled by 37.47% to $12.0 million in 2023, then surged by 52.01% to $18.2 million in 2024, then soared by 67.81% to $30.5 million in 2025.
• According to Business Quant data, Cash & Equivalents over the past three periods registered $30.5 million, $18.5 million, and $5.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.